Background
- Joined GreenSky in 2016
- Founder and CEO of a biotechnology company that develops novel cancer drugs
- Former Director of Drug Development at a biopharmaceutical company
- Expertise in chemistry, cancer research, immunology, regenerative medicine and gene therapy
- Authored more than 25 peer-reviewed publications and patents
- Co-Founded and former Board of Director of a national science policy conference and centre
Education
- Hon. BSc, Chemistry and Immunology, University of Toronto
- MSc, Immunology, University of Toronto
- MBA, University of Toronto (Rotman)
- PhD, Medical Biophysics, University of Toronto
In his free time
- Mentors early-career professionals and entrepreneurs